Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - CVS HEALTH Corp | cvs-20170331ex32279628d.htm |
| EX-32.1 - EX-32.1 - CVS HEALTH Corp | cvs-20170331ex321089b68.htm |
| EX-31.2 - EX-31.2 - CVS HEALTH Corp | cvs-20170331ex312be4eba.htm |
| EX-31.1 - EX-31.1 - CVS HEALTH Corp | cvs-20170331ex311f8a0d0.htm |
| 10-Q - 10-Q - CVS HEALTH Corp | cvs-20170331x10q.htm |
Letter re: Unaudited Interim Financial Information
May 2, 2017
The Board of Directors and Shareholders:
CVS Health Corporation
We are aware of the incorporation by reference in the Registration Statements (Nos. 333-49407, 333-34927, 333-28043, 333-91253, 333-63664, 333-139470, 333-141481, 333-167746 and 333-208805 on Form S-8, Nos. 333-187440 and 333-200217 on Form S-3ASR, Nos. 333-205156 and 333-210872 on Form S-3 and No. 333-210873 on Form S-4) of CVS Health Corporation of our report dated May 2, 2017, relating to the unaudited condensed consolidated interim financial statements of CVS Health Corporation that are included in its Form 10-Q for the quarter ended March 31, 2017.
|
|
/s/ Ernst & Young LLP |
|
|
|
|
Boston, Massachusetts |
|